Title: Pharmacokinetic enhancers in HIV therapeutics.
Journal: Clinical pharmacokinetics 20141001
Title: Cobicistat boosts the intestinal absorption of transport substrates, including HIV protease inhibitors and GS-7340, in vitro.
Journal: Antimicrobial agents and chemotherapy 20121001
Title: Effect of cobicistat on glomerular filtration rate in subjects with normal and impaired renal function.
Journal: Journal of acquired immune deficiency syndromes (1999) 20120901
Title: Combinational therapies for HIV: a focus on EVG/COBI/FTC/TDF.
Journal: Expert opinion on pharmacotherapy 20120901
Title: [A single tablet against HIV: new combination preparation improves therapy].
Journal: Deutsche medizinische Wochenschrift (1946) 20120801
Title: Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.
Journal: Lancet (London, England) 20120630
Title: Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks.
Journal: Lancet (London, England) 20120630
Title: Phase 2 study of cobicistat versus ritonavir each with once-daily atazanavir and fixed-dose emtricitabine/tenofovir df in the initial treatment of HIV infection.
Journal: AIDS (London, England) 20110924
Title: Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection.
Journal: AIDS (London, England) 20110327
Title: Pharmacokinetics and bioavailability of an integrase and novel pharmacoenhancer-containing single-tablet fixed-dose combination regimen for the treatment of HIV.
Journal: Journal of acquired immune deficiency syndromes (1999) 20101101
Title: Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer.
Journal: ACS medicinal chemistry letters 20100812
Title: Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity.
Journal: Clinical pharmacology and therapeutics 20100301
Title: Lianhong Xu, et al. Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer. ACS Med. Chem. Lett., 2010, 1 (5), pp 209–213
Title: Temesgen Z. Cobicistat, a pharmacoenhancer for HIV treatments. Drugs Today (Barc). 2013 Apr;49(4):233-7.
